AETERNUM HEALTH, INC. (AETN): Completion of Acquisition or Disposition of Assets
AETERNUM HEALTH, INC. (AETN) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0000764630 0000764630 2026-06-30 2026-06-30 0000764630 dei:FormerAddressMember 2026-06-30 2026-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 1
How this was made
The 30-second read
Why it matters
This 8-K Item 2.01 confirms the merger was consummated June 30, 2026, establishes new management/control (Paul Mann as President/CEO and sole board member), and documents the equity issuance and post-merger outstanding shares.
Market read
Deal completion plus a new capital structure and management/control change can reset expectations for valuation, dilution, and near-term trading behavior.
What to watch
Traders should focus on dilution/ownership mechanics (49M shares issued; Series B voting power) and the OTC/emerging-growth trading context, which can dominate near-term liquidity and volatility more than the strategic narrative.
Background
The company previously disclosed (Feb 23, 2026) a merger agreement where Aeternum Health LLC would merge into Shorepower, with Shorepower surviving and later changing its name and trading symbol to AETN.
Ticker impact
Aeternum Health (formerly Shorepower) consummated its merger on June 30, 2026 and issued new equity structure under the deal terms.
Potential near-term volatility as traders digest the completed merger, name/ticker change, and new capital structure; direction uncertain without valuation details.
This is a primary SEC 8-K confirming completion of the merger and issuance of 49,000,000 common shares plus 2,000,000 Series B preferred (40 votes each). However, the text provides limited financial metrics beyond minimum asset/cash amounts, so magnitude/direction of price impact is hard to pin down.
Market effects
Could be read as a pivot toward critical-minerals sourcing and longevity/health-related IP, potentially affecting investor sentiment toward small-cap “platform” plays in these themes.
No clear regional macro linkage beyond US-focused critical minerals and health/longevity narrative.
Limited; the disclosure is company-specific and does not provide cross-border deal terms beyond the stated mineral sourcing/geopolitical risk framing.
Counterpoint
The merger completion may be largely mechanical (name/ticker and asset transfer) with limited near-term fundamentals, so price may fade if investors expected more concrete commercialization milestones.
Key entities
- public_companyAETERNUM HEALTH, INC.
OTC-listed company confirming completion of the merger and new business focus; trading symbol AETN.
- public_companyShorepower Technologies, Inc.
Former name of the surviving entity; CEO Jeff Kim resigned upon completion.
- private_companyAeternum Health LLC
Merged into Shorepower as the acquired entity; transferred assets and received ownership in the surviving company.
- executivePaul Mann
Appointed President and CEO and sole member of the board of directors after the merger.
- executiveJeff Kim
Resigned as President and CEO and sole director of Shorepower at merger completion.
